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Isoniazid is used either alone or in combination with other drugs for the treatment of tuberculosis. It is
also used for the prevention of tuberculosis. Chronic treatment of Isoniazid may cause severe liver da-
mage leading to acute liver failure. The mechanism through which Isoniazid causes liver damage is in-
vestigated. Isoniazid treatment generates reactive oxygen species and induces apoptosis in Hep3B cells. It
induces antioxidative and apoptotic genes leading to increase in mRNA expression and protein levels in
Hep3B cells. Whole genome expression analysis of Hep3B cells treated with Isoniazid has resulted in
differential expression of various genes playing prime role in regulation of apoptotic, antioxidative, DNA
damage, cell signaling, cell proliferation and differentiation pathways. Isoniazid increased cytosolic Nrf2
protein level while decreased nuclear Nrf2 protein level. It also decreased ERK1 phosphorylation and
treatment of Hep3B cells with ERK inhibitor followed by Isoniazid resulting in increased apoptosis in
these cells. Two dimensional gel electrophoresis results have also shown differential expression of var-
ious protein species including heat shock proteins, proteins playing important role in oxidative stress,
DNA damage, apoptosis, cell proliferation and differentiation. Results suggest that Isoniazid induces
apoptosis through oxidative stress and also prevents Nrf2 translocation into the nucleus by reducing
ERK1 phosphorylation thus preventing cytoprotective effect.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Isoniazid is one of the cheapest and most effective drugs used
for the treatment of tuberculosis since 1950. Isoniazid is metabo-
lized in liver by various metabolizing enzymes such as N-acetyl
transferase which acetylates it into N-acetylisoniazid. N-acet-
ylisoniazid is then biotransformed into isonicotinic acid and
monoacetylhydrazine. Monoacetylhydrazine is N-hydroxylated by
the cytochrome P450 mixed oxidase system and causes hepato-
toxicity via formation of a reactive intermediate metabolite. An-
tituberculosis drug-induced hepatotoxicity (ATDH) is a serious
concern in tuberculosis treatment and management of hepato-
toxicity. However, the mechanism of toxicity of ATDH is not yet
known completely and further understanding of the mechanisms
associated with ATDH is greatly required to facilitate a rationalB.V. This is an open access article u
erma),
@gmail.com (J. Dewangan),
mail.com (M. Mishra),
cdri.res.in (S.K. Rath).approach in the treatment.
In this study the role of Nrf2 (Nuclear factor, erythoid 2-like 2)
is being investigated. Nrf2 induction occurs in the cell during
oxidative stress which is caused by various environmental factors
and chemicals including drugs [1–3]. These external stimuli induce
generation of reactive oxygen species which in turn trigger Nrf2
activation and its translocation into the nucleus [4]. After its
translocation into the nucleus, it binds to antioxidative response
elements (ARE) sequences of various antioxidative and cytopro-
tective genes and then induces their transcription [5–7]. Protein
products formed from these transcribed antioxidative and cyto-
protective genes decrease reactive oxygen species and reduce the
cell damages caused by them. Several reports have suggested a
protective action for Nrf2-ARE signaling pathway against CYP2E1-
dependent hepatic oxidative injury [8,9] indicating Nrf2-ARE
pathway may exhibit a protective effect on INH and RFP-induced
hepatotoxicity.
Extracellular signal regulated kinase 1 (ERK1) in the cytosol
acts in signaling cascade and phosphorylate Nrf2 and induces its
translocation into the nucleus [10]. ERK1 regulates various cellular
processes like cell proliferation, cell differentiation and cell cyclender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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this study we hypothesized that Isoniazid inhibits Nrf2 phos-
phorylation by reducing ERK1 phosphorylation and interferes its
translocation into the nucleus.2. Results
2.1. Cell viability assay and IC50 determination
Hep3B cells were treated with 20, 40, 60, 80, 100, 120 and
140 mM Isoniazid concentrations while controls were treated with
DMEM medium. Cell viability observed was 94.73% at 20 mM INH
while at 140 mM of INH cell viability was 35.53% with controls
having 100% cell viability. At 80 mM of INH 50% cell viability was
observed. Therefore, IC50 for Hep3B cells for INH was calculated as
80 mM [Fig. 1].
2.2. Reactive oxygen species estimation
Isonaizid induced reactive oxygen species (ROS) generation in
Hep3B cells in a dose dependent fashion. ROS generation was in-
creased with increase in Isoniazid concentration in comparison to
controls, where 0.36% cells generated ROS. When Hep3B cells were
treated with 5, 10 and 20 mM INH, ROS was generated by 10.35%,
27.65% and 38.50% of the cells respectively [Fig. 2(A)].
2.3. Apoptosis induction
In control Hep3B cell population, 0.36% of cells were in apop-
tosis while in cells treated with 5, 10 and 20 mM INH, percentage
of cells undergoing apoptosis was found to be at 1.42, 23.34 and
48.35 respectively [Fig. 2(B)]. The result showed that Isoniazid
induces apoptosis in Hep3B cells in a dose dependent manner.
2.4. Messenger RNA level of apoptotic and antioxidative genes
mRNA levels of apoptotic (Cyt C, Caspase 9) and antioxidative
genes (Keap1, Nrf2) were observed to be signiﬁcantly increased in
a dose dependent fashion in Hep3B cells treated with different
Isoniazid concentrations as compared to controls [Fig. 3(A)].
2.5. Caspase activity assay
Activities of Caspase 9 and Caspase 3 were increased in Hep3B
cells treated with 10 and 20 mM of Isoniazid respectively [Fig. 3
(B)]. When caspase inhibitors were added to cell suspensionFig. 1. Cell viability assay of Hep3B cells treated with different concentrations of
Isoniazid for IC50 determination (INH-Isoniazid).before adding caspase substrate the activities of both Caspase
9 and Caspase 3 were observed to decrease in Hep3B cells.
2.6. Differential gene expression study
Following 20 mM INH treatment in Hep3B cells, whole genome
mRNA expression was assessed by microarray analysis. A high
statistically stringent criterion (po0.05 and 2.2 fold change) for
up-regulated genes ﬁltered 39 genes (Table 2) while a high sta-
tistically stringent criterion (po0.05 and 2.5 fold change) for
down-regulated genes ﬁltered 64 genes (Table 3). Few differen-
tially expressed transcript cluster Ids have shown no sequence
similarity with any known genes and have not been assigned any
biological function yet.
2.7. Affected pathways
Differentially expressed genes were clustered by IPA (Ingunity
Pathway Analysis, Qiagen) software in which genes were classiﬁed
based upon functional category and pathways. Genes belonging to
same mechanisms were joined together to form a single pathway.
Major pathways that showed signs of Isoniazid induced pertur-
bations included development function, cellular movement, post-
translational modiﬁcations, energy production, cell to cell signal-
ing, cell death, survival, cell growth and proliferation pathways
[Figs. 4 and 5].
2.8. Validation of microarray results by quantitative real time PCR
analysis
Differential expression of four up-regulated genes (Bak1,
SH3KBP1, GADD45B and SNAI2) and four down-regulated genes
(NDRG1, PIM1, UCP2 and THBS3) as observed in microarray analysis
were further validated by quantitative real time PCR analysis
[Fig. 6(A) and (B)]. The up regulated genes Bak1, SH3KBP1,
GADD45B and SNAI2 were observed to be up-regulated by 6.91,
4.87, 5.13 and 4.39 folds respectively, following 20 mM INH
treatment to Hp3B cells. Similarly the down-regulated genes
NDRG1, PIM1, UCP2 and THBS3 were down regulated by 3.87, 4.56,
6.34 and 5.02 fold respectively, following 20 mM INH treatment to
Hep3B cells.
2.9. Expression of apoptotic genes at protein level
Isoniazid induced oxidative stress in Hep3B cells was con-
ﬁrmed by Cyt C release from mitochondrial inner membrane. Cy-
tochrome C released from mitochondrial inner membrane was
observed by Western blot analysis and this increase was propor-
tional to Isoniazid concentrations. Cyt C binds apoptotic protease
activating factor 1 (Apaf 1) which in turn binds to Procaspase
9 and converts it into Caspase 9. Caspase 9 protein level in Iso-
niazid treated Hep3B cells, was also observed to increase in a dose
dependent fashion. Protein amount of both Cyt C and Caspase
9 was increased, from 5 mM to 10 and 20 mM of INH in compar-
ison to control Hep3B cells [Fig. 7(A)]. Keap1 protein was also
observed to increase in Hep3B cells treated with Isoniazid and this
increase in Keap1 protein was also proportional to Isoniazid con-
centrations [Fig. 7(A)]. Densitometric results of bands of Cyto-
chrome C, Caspase 9 and Keap1 are shown in Fig. S1.
2.10. Cytosolic and nuclear Nrf2 protein level
Cytosolic Nrf2 protein level was observed to be increased in
Hep3B cells treated with Isoniazid while the nuclear Nrf2 protein
was observed to decrease [Fig. 7(B)]. This change in cytosolic and
nuclear Nrf2 protein levels was proportional to Isoniazid
Fig. 2. Estimation of reactive oxygen species (ROS) generation and measurement of apoptosis induction by different concentrations of Isoniazid in Hep3B cells. (A) Flow
cytometry results of Hep3B cells incubated with DCFDA following 24 h incubation of different concentrations of Isoniazid for estimation of reactive oxygen species gen-
eration (ROS). (B) Flow cytometry results of Hep3B following 24 h incubation of different concentrations of Isoniazid for measurement of apoptosis induction.
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from 5 mM to 10 and 20 mM of INH, as compared to control Hep3BFig. 3. (A) Quantitative real time PCR analysis for relative mRNA expression of apoptot
centrations (5, 20 and 40 mM) of Isoniazid. For normalization β-actin was used as house
cells following treatment with different Isoniazid concentrations (10 mM and 20 mM).cells while protein amount of nuclear Nrf2 was decreased, from
5 mM to 10 and 20 mM of Isoniazid, as compared to control Hep3Bic and antioxidative genes in Hep3B cells following treatment with different con-
keeping control. (B) Diagram showing Caspase 9 and Caspase 3 activities in Hep3B
Table 1
Primer sequences used for real time PCR for Hep3B cell lines.
S.No. Primers Sequence
1 Actin FP 5′-ACTACCTCATGAAGATCCTC-3′
Actin RP 5′-CTAGAAGCATTTGCGGTCGACGATGG-3′
2 CytC FP 5′-GGACCTCTTTACCTTCTCCCC-3′
CytC RP 5′-GTTGGGACATACATCAGCAGC-3′
3 Caspase9 FP 5′-GCGACCTGACTGCCAAGAAA-3′
Caspase9 FP 5′-TCACAATCTTCTCGACCGACA-3′
4 Nrf2 FP 5′-TCAGCGACGGAAAGAGTATGA-3′
Nrf2 RP 5′-CCACTGGTTTCTGACTGGATG-3′
5 Keap1 FP 5′-CTGGAGGATCATACCAAGCAG-3′
Keap1 RP 5′-GAACATGGCCTTGAAGACAGG-3′
6 BAK1 FP 5′-GTTTTCCGCAGCTACGTTTTT-3′
BAK1 RP 5′-GCAGAGGTAAGGTGACCATCTC-3′
7 SH3KBP1 FP 5′-CATCGACGTAGGCTGGTGG-3′
SH3KBP1 RP 5′-CCTTCCTTTTCAAAGTCCGGTG-3′
8 GADD45B FP 5′-TGCTGTGACAACGACATCAAC-3′
GADD45B RP 5′-GTGAGGGTTCGTGACCAGG-3′
9 SNAI2 FP 5′-TGTGACAAGGAATATGTGAGCC-3′
SNAI2 RP 5′-TGAGCCCTCAGATTTGACCTG-3′
10 NDRG1 FP 5′-CTCCTGCAAGAGTTTGATGTCC-3′
NDRG1 RP 5′-TCATGCCGATGTCATGGTAGG-3′
11 PIM1 FP 5′-GAGAAGGACCGGATTTCCGAC-3′
PIM1 RP 5′-CAGTCCAGGAGCCTAATGACG-3′
12 UCP2 FP 5′-GGAGGTGGTCGGAGATACCAA-3′
UCP2 RP 5′-ACAATGGCATTACGAGCAACAT-3′
13. THBS3 FP 5′-ATGGAGACGCAGGAACTTCG-3′
THBS3 RP 5′-AGCTACCATCTGCCGAGACT-3′
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Nrf2 are shown in Fig. S2.2.11. Phosphorylation of ERK1 into Phospho-ERK1
Phosphorylation of extra-cellular regulated kinase 1 (ERK1)
protein into phospho-ERK1 was found to be decreased in the cy-
tosol of Hep3B cells following Isoniazid treatment as compared to
control Hep3B cells [Fig. 7(C)]. Phosphorylation of ERK1 in Hep3B
cells was decreased when we increased INH concentrations from
5 mM to 10 and 20 mM. Densitometric results of bands of ERK1
and phospho-ERK1 are shown in Fig. S3.2.12. ERK1 inhibitor and apoptosis
When Hep3B cells were treated with ERK inhibitor, it induced
apoptosis. 50 mM of ERK inhibitor induced apoptosis in 5.32% of
Hep3B cells [Fig. 8(B)] while cells treated with 10 mM and 20 mM
of INH induced apoptosis in 4.11% and 7.48% of Hep3B cells [Fig. 8
(C) and (D)] respectively compared to untreated Hep3B cells [Fig. 8
(A)]. When Hep3B cells were pre-treated with 50 mM ERK inhibitor
followed by 10 mM and 20 mM of INH, percent of Hep3B cells
undergoing apoptosis was increased and it was 16.45 and 23.55
respectively compared to untreated Hep3B cells [Fig. 8(E) and (F)].2.13. Two dimensional gel electrophoresis
After analyzing two dimensional gels, 30 protein spots, which
were differentially regulated, were selected and cut [Fig. 9]. These
spots were either up-regulated by 41.5 times or down-regulated
by o0.65 times. We observed that out of 30, 15 proteins were up-
regulated and 15 proteins were down-regulated (Table 4). These
proteins were identiﬁed by MALDI TOF/TOF analysis. These dif-
ferentially expressed proteins were found to have role in oxidative
stress, apoptosis, cell proliferation, t-RNA export, protein synth-
esis, development and cytoskeleton formation.3. Discussion
Drug induced liver injury during the treatment of tuberculosis
infection, is a major challenge to modern hepatology [15,16].
Therefore, the assessment and monitoring of the hepatotoxicity of
anti-tuberculosis drugs for prevention of liver injury are great
concerns during disease treatment. The exact mechanism of anti-
tuberculosis drugs induced hepatotoxicity is not clearly under-
stood yet. Some authors point to oxidative stress in hepatocytes by
anti-tuberculosis drugs [17,18]. Isoniazid is the most effective
agent against tuberculosis and is used both for the treatment and
the prophylaxis of this disease [19]. Toxic metabolites may also
play an important role in the development of anti-TB drug induced
hepatotoxicity (ATDH) [20].
During oxidative stress, ROS is generated and it attacks the
mitochondrial membrane resulting in Cyt C release. This released
Cyt C binds to Apoptotic protease activating factor 1 (Apaf-1)
which in turn binds to pro-caspase-9 to form apoptosome. The
apoptosome cleaves pro-caspase-9 to its active form caspase-9,
which in turn activates the effector caspase-3 [21].
In Hep3B cells, twenty-four hours after treatment of 20 mM
Isoniazid led to signiﬁcant increase in number of annexin V FITC
positive cells demonstrating apoptotis. ROS generation and apop-
tosis were found to be directly proportional to Isoniazid con-
centrations in Hep3B cells in this study. Apoptosis can be induced
through two distinct pathways; one involves the ligation of the
TNF/Fas-receptor with its ligand and followed by caspase-8 acti-
vation, leading to either direct activation of caspase-3, or through
merger with the mitochondrial pathway via cleavage of the Bcl-2
family member, Bid. The other pathway is the mitochondria
mediated caspase-9 activation pathway. Both pathways converge
in caspase-3, culminating to cell death. Subsequent accumulation
of cytochrome c in the cytosol has been shown to be responsible
for activation of downstream proteolytic caspase and DNA frag-
menting enzymes responsible for apoptotic cell death, and sub-
sequent release of cytochrome c to peripheral circulation [22,23].
In the present study, it was observed that relative mRNA ex-
pressions of apoptotic genes (Cyt C and Caspase 9) as well as an-
tioxidative genes (Keap1 and Nrf2) were increased in Hep3B cells
following INH treatment. Further it was conﬁrmed by activity as-
say of Caspase 9 and its down stream effector Caspase 3 that
apoptosis in Hep3B cells is occurring through intrinsic pathway
and not through extrinsic pathway following INH treatment. In
Hep3B cells, administration of 10 and 20 mM of INH induced ac-
tivation of caspase 9 and caspase 3 and it increased from 10 to
20 mM of INH. When cell suspensions of Hep3B cells incubated
with 20 mM of INH for twenty-four hours were treated with cas-
pase inhibitor following administration of caspase substrate, ac-
tivities of both caspases were observed to be decreased.
Further, whole genome expression analysis was performed in
Hep3B cells treated with 20 mM of Isoniazid to identify differen-
tially expressed genes and their involvement in different pathways
by microarray study. High throughput expression proﬁling made it
possible for identiﬁcation of various genes whose expression has
changed following INH treatment. Their differential expression
indicates hindrance of various roles in diverse pathways. Hep3B
cells treated with Isoniazid resulted in differential regulation of
103 genes of which 39 were up-regulated and 64 were down-
regulated. Most of the genes were engaged in apoptosis, oxidative
stress, cell proliferation, post-translational modiﬁcation, cell sig-
naling, cellular movement and developmental disorder. In addi-
tion, validation of few important differentially expressed genes in
microarray ﬁndings using quantitative real time PCR [24] sub-
stantiates these results. As a result, identiﬁcation of genes with
similar expression changes, at such a high stringency indicates
important biological functions under these circumstances.
Table 2
List of differentially up-regulated genes identiﬁed with p-value cut-off 0.05 and fold change 42.2 following Isoniazid treatment to Hep3B cells at 20 mM concentration.
S.No Transcripts
cluster Id
Gene symbol Gene description Regulation Log FC ([Treat]
vs [Control])
FC ([Treat] vs
[Control])
Amino acid metabolism, developmental disorder, hereditary disorder
1. 7953211 C12orf5 Chromosome 12 open reading frame 5 Up 1.167182 2.245726
2. 8153457 EEF1D Eukaryotic translation elongation factor 1 delta (guanine
nucleotide exchange protein)
Up 1.152429 2.2228777
3. 8047097 GLS Glutaminase Up 1.271881 2.4147623
4. 8121144 MANEA Mannosidase, endo-alpha Up 1.543634 2.915279
5. 8110861 MRPL36 Mitochondrial ribosomal protein L36 Up 1.547498 2.9230971
6. 8159687 MRPL41 Mitochondrial ribosomal protein L41 Up 1.248036 2.3751783
7. 7985757 MRPS11 Mitochondrial ribosomal protein S11 Up 1.221251 2.331488
8. 8156043 PSAT1 Phosphoserine aminotransferase 1 Up 1.228868 2.3438294
9. 8006183 SUZ12P Suppressor of zeste 12 homolog pseudogene Up 1.619368 3.0724032
10. 8165703 UIMC1 Ubiquitin interaction motif containing 1 Up 1.324133 2.5038245
11. 7936346 ZDHHC6 Zinc ﬁnger, DHHC-type containing 6 Up 1.36511 2.5759594
12. 8006377 ZNF207 ZInc ﬁnger protein 207 Up 1.273516 2.4175005
13. 7995252 ZNF720 Zinc ﬁnger protein 720 Up 1.182164 2.2691684
14. 7997904 ZNF778 Zinc ﬁnger protein 778 Up 1.935808 3.8259227
Infectious disease, cell proliferation, gene expression
15. 8125766 BAK1 BCL2-antagonist/killer 1 Up 1.158309 2.2319558
16. 8129562 CTGF Connective tissue growth factor Up 1.230378 2.3462842
17. 8112914 DHFR Dihydrofolate reductase Up 1.695785 3.2395313
18. 8154765 DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 Up 1.172203 2.2535555
19. 7980535 DYNLL1 Dynein, light chain, LC8-type 1 Up 1.512186 2.8524194
20. 7948839 NXF1 Nuclear RNA export factor 1 Up 1.880587 3.6822488
21. 8147654 POLR2K Polymerase (RNA) II (DNA directed) polypeptide K,
7.0 kDa
Up 1.241887 2.365076
22. 8060758 PRNP Prion protein Up 1.313068 2.4846935
23. 7914791 SFPQ Splicing factor proline/glutamine-rich (polypyrimidine
tract binding protein associated)
Up 1.217865 2.3260224
24. 8165674 SH3KBP1 SH3-domain kinase binding protein 1 Up 1.336754 2.5258236
25. 8150698 SNAI2 Snail homolog 2 (Drosophila) Up 1.375106 2.5938694
26. 7992789 TNFRSF12A Tumor necrosis factor receptor superfamily, member
12A
Up 1.205973 2.3069274
RNA processing, DNA damage
27. 7898375 RNU1A|RNU1A3|RNU1C1|
RNU1C2|RNU1G2|RNU1F1|
RNU1G1|RNU1G3|GSTM2
RNA, U1A small nuclear|RNA, U1A3 small nuclear|RNA,
U1C1 small nuclear|RNA, U1C2 small nuclear|RNA, U1G2
small nuclear|RNA, U1F1 small nuclear|RNA, U1G1 small
nuclear|RNA, U1G3 small nuclear|glutathione S-trans-
ferase mu 2 (muscle)
Up 1.19027 2.2819536
28. 7911329 SEPT14|C20orf69|
DKFZP434B2016
Septin 14|chromosome 20 open reading frame 69|similar
to hypothetical protein LOC284701
Up 1.383161 2.6083918
29. 7942783 C11orf67|INTS4 Chromosome 11 open reading frame 67|integrator
complex subunit 4
Up 1.189677 2.2810163
30. 7949916 CHKA Choline kinase alpha Up 1.142337 2.207383
31. 8005553 SNORD3A|SNORD3B-1|SNORD3B-
2|SNORD3C|SNORD3D
Small nucleolar RNA, C/D box 3A|small nucleolar RNA, C/
D box 3B-1|Usmall nucleolar RNA, C/D box 3B-2|small
nucleolar RNA, C/D box 3C|small nucleolar RNA, C/D box
3D
Up 2.225389 4.676368
32. 8024485 GADD45B Growth arrest and DNA-damage-inducible, beta Up 1.182639 2.2699163
33. 8031646 LOC100288114|MGC9913 Hypothetical protein LOC100288114|hypothetical pro-
tein MGC9913
Up 1.318619 2.494272
34. 8035779 ZNF626|ZNF93|ZNF253|
LOC100128975
Zinc ﬁnger protein 626|zinc ﬁnger protein 93|zinc ﬁnger
protein 253| similar to zinc ﬁnger protein 626
Up 1.64639 3.1304922
35. 8044961 RNU4ATAC RNA, U4atac small nuclear (U12-dependent splicing) Up 1.146462 2.213704
36. 8137008 C7orf11 Chromosome 7 open reading frame 11 Up 1.158495 2.2322443
37. 8145795 LOC100293539 Similar to ribosomal protein 10 Up 1.159232 2.2333846
38. 8148000 C8orf85 Chromosome 8 open reading frame 85 Up 1.320166 2.4969485
39. 8161575 CBWD5|CBWD3|CBWD1|CBWD6|
CBWD7|CBWD2|LOC653510
COBW domain containing 5|COBW domain containing 3|
COBW domain containing 1
Up 1.209761 2.3129926
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ﬁve genes: C12orf5, GLS, GADD45B, DDIT4 and GLUL were involved
in oxidative stress and DNA damage. Genes like BAK1, SH3KBP1,
SNAI2, TNFRSF12A and MAGED1 were involved in programmed cell
death and DHFR, CTGF, ASS1, ID1, NDRG1, PIM1, ARHGAP19, PFKL,
THBS3 and ACCN2 were found to play role in the cell proliferation.
Similarly seven genes i.e. UIMC1, BMP2, IRS4, NOG, EXOC4, IFITM1
and NRN1 were found to be engaged in cell signaling pathways.
One of the identiﬁed genes was Chromosome 12 open reading
frame 5 (C12orf5) that increases NADPH production to help limitreactive oxygen species (ROS) and lowers cell death [25]. In BCL2-
antagonist/killer 1 (BAK1), SH3-domain kinase binding protein 1
(SH3KBP1), Snail homolog 2 (SNAI2), Tumor necrosis factor re-
ceptor superfamily (TNFRSF12A), member 12A and Melanoma an-
tigen family D 1 (MAGED1) genes BAK1, SH3KBP1, SNAI2 and
TNFRSF12A were up-regulated while MAGED1 was down-regulated
following Isoniazid treatment. BAK is a fundamental outer mi-
tochondrial membrane protein and a key cell death initiator [26].
It further conﬁrms that INH induced apoptosis through intrinsic
pathway.
Table 3
List of differentially down-regulated genes identiﬁed with p-value cut-off 0.05 and fold change 42.5 following Isoniazid treatment to Hep3B cells at 20 mM concentration.
S.No. Transcripts Cluster
Id
Gene Symbol Gene Description Regulation Log FC ([Treat] vs
[Control])
FC ([Treat] vs
[Control])
Cell death and survival, cellular development, nervous system development and function
1. 8158671 ASS1 Argininosuccinate synthetase 1 Down 1.58433 2.99868
2. 8077441 BHLHE40 Basic helix-loop-helix family, member e40 Down 2.2831 4.86722
3. 8060850 BMP2 Bone morphogenetic protein 2 Down 1.528 2.88387
4. 7928308 DDIT4 DNA-damage-inducible transcript 4 Down 2.79568 6.9436
5. 8019392 FASN Fatty acid synthase Down 1.66354 3.16794
6. 8151457 HEY1 Hairy/enhancer-of-split related with YRPW motif 1 Down 1.47183 2.77374
7. 8061564 ID1 Inhibitor of DNA binding 1, dominant negative helix-loop-helix
protein
Down 1.56954 2.96809
8. 8174444 IRS4 Insulin receptor substrate 4 Down 2.78425 6.88877
9. 7956301 LRP1 Low density lipoprotein-related protein 1 (alpha-2-macro-
globulin receptor)
Down 1.41548 2.66749
10. 8153002 NDRG1 N-myc downstream regulated 1 Down 1.79439 3.46868
11. 8008627 NOG Noggin Down 1.38934 2.6196
12. 8046408 PDK1 Pyruvate dehydrogenase kinase, isozyme 1 Down 1.74592 3.35409
13. 8008263 PDK2 Pyruvate dehydrogenase kinase, isozyme 2 Down 1.47028 2.77077
14. 8119161 PIM1 Pim-1 oncogene Down 1.46096 2.75292
15. 8145977 PLEKHA2 Pleckstrin homology domain containing, family A (phosphoi-
nositide binding speciﬁc) member 2
Down 1.45269 2.73718
16. 8166469 SAT1 Spermidine/spermine N1-acetyltransferase 1 Down 1.41249 2.66197
Developmental disorder, hereditary disorder, neurological disease
17. 8080168 ACY1 Aminoacylase 1 Down 1.74711 3.35686
18. 7935403 ARHGAP19 Rho GTPase activating protein 19 Down 1.3689 2.58274
19. 7967072 COQ5 Coenzyme Q5 homolog, methyltransferase (S. cerevisiae) Down 1.48488 2.79895
20. 7923596 ETNK2 Ethanolamine kinase 2 Down 1.67516 3.19356
21. 8046524 HOXD13 Homeobox D13 Down 1.71756 3.2888
22. 7915827 LRRC41 Leucine rich repeat containing 41 Down 1.34957 2.54836
23. 8148917 MFSD3 Major facilitator superfamily domain containing 3 Down 1.96708 3.90977
24. 7984922 MPI Mannose phosphate isomerase Down 1.40341 2.64525
25. 8085431 NUP210 Nucleoporin 210 kDa Down 1.51115 2.85037
26. 8165711 PLCXD1 Phosphatidylinositol-speciﬁc phospholipase C, X domain con-
taining 1
Down 1.6955 3.2389
27. 8088664 SUCLG2 Succinate-CoA ligase, GDP-forming, beta subunit Down 1.63177 3.09893
28. 7980720 TTC7B Tetratricopeptide repeat domain 7B Down 1.33148 2.5166
29. 8169598 ZCCHC12 Zinc ﬁnger, CCHC domain containing 12 Down 1.93981 3.83656
30. 8166500 ZFX Zinc ﬁnger protein, X-linked Down 1.35301 2.55444
31. 8055377 ZRANB3 Zinc ﬁnger, RAN-binding domain containing 3 Down 1.63365 3.10297
Amino acid metabolism, post-translational modiﬁcation, small molecule biochemistry
32. 8082444 ACAD9 Acyl-Coenzyme A dehydrogenase family, member 9 Down 1.43318 2.70041
33. 7901110 AKR1A1 Aldo-keto reductase family 1, member A1 (aldehyde reductase) Down 1.68036 3.2050
34. 8013660 ALDOC Aldolase C, fructose-bisphosphate Down 1.74079 3.34219
35. 7981427 CKB Creatine kinase, brain Down 1.39591 2.63155
36. 8036602 ECH1 Enoyl Coenzyme A hydratase 1, peroxisomal Down 1.54757 2.92324
37. 7953532 ENO2 Enolase 2 (gamma, neuronal) Down 1.34501 2.54032
38. 8136293 EXOC4 Exocyst complex component 4 Down 1.3335 2.52013
39. 8159373 FAM69B Family with sequence similarity 69, member B Down 1.40775 2.65322
40. 8154951 GLUL Glutamate-ammonia ligase (glutamine synthetase) Down 1.8001 3.48245
41. 8095303 LPHN3 Latrophilin 3 Down 1.49011 2.8091
42. 7934278 P4HA1 Prolyl 4-hydroxylase, alpha polypeptide I Down 1.81848 3.52709
43. 8027330 PCGF6 Polycomb group ring ﬁnger 6 Down 1.7239 3.30328
44. 8091283 PLOD2 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 Down 1.40192 2.64253
45. 7944382 VPS11 Vacuolar protein sorting 11 homolog Down 1.41151 2.66016
Connective tissue disorders, developmental disorder, hereditary disorder
46. 8035494 FKBP8 FK506 binding protein 8, 38 kDa Down 1.33595 2.52441
47. 8101324 HNRNPD Heterogeneous nuclear ribonucleoprotein D (AU-rich element
RNA binding protein 1, 37 kDa)
Down 1.32701 2.50882
48. 7937335 IFITM1 Interferon induced transmembrane protein 1 (9–27) Down 1.74811 3.35919
49. 7969574 KRT18 Keratin 18 Down 1.52955 2.88695
50. 7938777 LDHA Lactate dehydrogenase A Down 1.42929 2.69313
51. 8167656 MAGED1 Melanoma antigen family D, 1 Down 1.46751 2.76543
52. 8168215 MED12 Mediator complex subunit 12 Down 1.60053 3.03255
53. 8013120 PEMT Phosphatidylethanolamine N-methyltransferase Down 1.54938 2.92691
54. 8069057 PFKL Phosphofructokinase, liver Down 1.44216 2.71727
55. 8156905 TMEFF1 Transmembrane protein with EGF-like and two follistatin-like
domains 1
Down 1.38198 2.60625
56. 7950307 UCP2 Uncoupling protein 2 (mitochondrial, proton carrier) Down 1.41558 2.66768
57. 7993872 UQCRC2 Ubiquinol-cytochrome c reductase core protein II Down 1.33492 2.52262
Cell-to-cell signaling and interaction, embryonic development, tissue development
58. 8170393 CXorf40A Chromosome X open reading frame 40A Down 1.43056 2.69551
59. 8123739 NRN1 Neuritin 1 Down 1.64898 3.13611
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Table 3 (continued )
S.No. Transcripts Cluster
Id
Gene Symbol Gene Description Regulation Log FC ([Treat] vs
[Control])
FC ([Treat] vs
[Control])
Cellular development, embryonic development, nervous system development and function
60. 7920664 THBS3 Thrombospondin 3 Down 1.3366 2.52556
61. 7934906 ACTA2 Actin, alpha 2, smooth muscle, aorta Down 1.65103 3.14058
62. 7955317 ACCN2 Amiloride-sensitive cation channel 2, neuronal Down 1.62671 3.08809
63. 8098604 ANKRD37|
UFSP2
Ankyrin repeat domain 37|UFM1-speciﬁc peptidase 2 Down 1.98257 3.95196
64. 8178609 VARS|VARS2 Valyl-tRNA synthetase|valyl-tRNA synthetase 2, mitochondrial
(putative)
Down 1.36886 2.58267
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(DHFR and CTGF) were up-regulated while Argininosuccinate
synthetase1(ASS1), Inhibitor of DNA binding 1 (ID1), N-myc
downstream regulated 1(NDRG1), Pim-1 oncogene (PIM1), Rho
GTPase activating protein 19(ARHGAP19), Phosphofructokinase
(PFKL) liver, Thrombospondin 3 (THBS3), and Amiloride-sensitive
cation channel 2 neuronal (ACCN2) genes were down-regulated
following Isoniazid treatment. All the above genes play an im-
portant role in cell proliferation. Out of the 10 genes having role in
cell proliferation, 8 were down-regulated following Isoniazid
treatment indicating that INH prevents cell proliferation.
At the basal level, Nrf2 retained in the cytosol by binding its
inhibitor Keap1 or INrf2 [(Kelch like ECH-associated protein 1 or
inhibitor of Nrf2)] [27]. The xenobiotics and antioxidants lead to
dissociation of Nrf2 from INrf2 resulting in stabilization andFig. 4. Cardiovascular system development and function, connective tissue development an
cells. In the shown pathway genes represented by red color were upregulated while genes rnuclear translocation of Nrf2. Nrf2 attaches to ARE and induces the
expression of defensive genes.
The Hep3B cells treated with 5, 10 and 20mM of INH showed an
increased level of cytosolic Nrf2 protein level while a decreased level
of nuclear Nrf2 protein level. ERK2/ERK1 (also known as p42/
p44MAPK, in that order, and authoritatively namedMAPK 1 and 3) are
activated through a sequential phosphorylation cascade that ampliﬁes
and transduces signals from the cell membrane to the nucleus.
Phospho-ERK activates Nrf2 by phosphorylating it [10] and
Nrf2 translocates into the nucleus by Karyopherin β1[28]. This
study has shown that Isoniazid decreases ERK phosphorylation
following INH treatment to Hep3B cells and interferes with the
activation and translocation of Nrf2 into the nucleus. Isoniazid
does not change ERK level, but decreases activation of existing ERK
protein as evident from decreased amount of phosphorylatedd function, embryonic development pathway affected by Isoniazid treatment in Hep3B
espresented by green color were downregulated by Isoniazid treatment to Hep3B cells.
Fig. 5. Amino acid metabolism, post-translational modiﬁcation, small molecule biochemistry pathway affected by Isoniazid treatment in Hep3B cells. In the shown pathway
genes represented by red color were upregulated while genes respresented by green color were downregulated by Isoniazid treatment to Hep3B cells.
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cation, Nrf2 may not be able to bind ARE sequences of the anti-
oxidative and cytoprotective genes and activate them.
In 2D gel electrophoresis results of Hep3B cells treated with INH,
we have selected only those protein spots which were either up-
regulated by 41.5 fold or down-regulated by o0.65 fold. It was ob-
served that total 30 proteins were differentially expressed under the
criteria selected by us. Out of these 30 differentially expressed pro-
teins, 15 proteins were detected to be up-regulated whereas 15 pro-
teins were detected to be down-regulated. Thirteen differentially ex-
pressed proteins were found to be engaged in oxidative stress and
DNA damage response. These proteins were Chaperonin Hsp60, Stress
induced phosphoprotein1, 60 kDa Heat shock protein, Creatine kinase
B, Coﬁlin, Inorganic pyrophoaphatase, Chain A Horf6A Novel Human
Peroxidase enzyme, Alpha globin, Beta globin, Rho protein GDP dis-
sociation inhibitor, Endoplasmin precursor, Transformation upregu-
lated nuclear protein and Chain A Tapasin Erp57. Creatine kinase BFig. 6. Bar graph presents the fold change in selected genes with quantative real time-P
(A) at po0.05 and up regulated 42.2 fold or (B) at po0.05 and down regulated 42.5(CKB), a cytosolic isoform of creatine kinase, demonstrates up-regu-
lated expression in a variety of cancers. CKB knockdown reduced
glucose consumption and lactate production, and raised ROS produc-
tion and oxygen consumption. This recommended that CKB knock-
down reduced cytosolic glycolysis and resulted in a tumor suppressive
metabolic state in Skov3 cells [29]. Coﬁlin1 (CFL-1) over-expression
enhances radiosensitivity and is associated with reduced DNA repair
capacity [30].
Five differentially expressed proteins observed from the 2D
results in Hep3B cells treated with INH had role in apoptosis
pathway. These proteins were BiP protein, Peroxiredoxin 4, Nu-
cleophosmin/B23, EF1A1 and Eukaryotin translation initiator. The
endoplasmic reticulum is the place where folding occurs for newly
synthesized proteins that are destined for the cell surface. Ad-
ditionally, it is the primary cellular storage site for calcium. Cal-
cium homeostasis is needed for proper polypeptide folding and
secretion of selective proteins as well as for intracellular signalingCR. The genes were selected from those that showed differential expression either
fold in microarray analysis after 20 mM Isoniazid treatment to Hep3B cells.
Fig. 7. Effect of different concentrations (5 , 10 , and 20 mM) of Isoniazid on protein levels of various proteins, (A) Western blot result of Cyt C, Caspase 9 and Keap1 following
treatment with Isoniazid to Hep3B cells. (B) Western blot result of Cytosolic and Nuclear Nrf2 protein level following treatment with Isoniazid. (C) Western blot result of
ERK1 and Phospho-ERK1 following treatment with Isoniazid to Hep3B cells. All the experiments were performed in triplicate independently and image is representative
image of one of them. For cytosolic fraction β-actin was used as housekeeping and for nuclear fraction Lamin B was used as housekeeping (5FU- 5-ﬂuorouracil, tBHQ- tertiary
butylhydroquinone, INH- Isoniazid).
A.K. Verma et al. / Redox Biology 6 (2015) 80–9288events that occur inside the cell. BiP/GRP78 is a lumenal stress
protein of the endoplasmic reticulum (ER) that interacts withFig. 8. Measurement of apoptosis induced by different concentrations of Isoniazid and co
(A) Untreated Hep3B cells, (B) Hep3B cells treated with 50 mM ERK inhibitor, (C) Hep3B
cells treated with combination of 50 mM ERK inhibitor and 10 mM INH, (F) Hep3B cells tr
performed in triplicate independently.polypeptide folding intermediates transiting the secretory com-
partment [31]. Enzymes CK2, PKC, PLK1, CDKs, and PKA couldmbination of Isoniazid and ERK inhibitor in Hep3B cells by Annexin V FITC method.
cells treated with 10 mM INH, (D) Hep3B cells treated with 20 mM INH, (E) Hep3B
eated with combination of 50 mM ERK inhibitor and 20 mM INH. Experiments were
Fig. 9. Two dimensional gel electrophoresis of proteins isolated from Hep3B cells following 20 mM INH treatment. 2D gel images of Control and 20 mM INH treated Hep3B
cells showing differential expression of various proteins spots. All the experiments were performed in triplicate independently and image is representative image of one of
them.
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is associated to cellular processes such as cell survival, apoptosis,
cell proliferation, and reply to DNA damage stimulus [32]. eEF1A1
expression has clear effects on the proliferation enhancement and
apoptosis inhibition of Jurkat cells, which may be intervened by
the up-regulation of PI3K/Akt/NF-κB and PI3K/Akt/ mTOR signal-
ing pathway [33].
Six differentially expressed proteins observed were found to
have role in Cell proliferation and differentiation. These were Cy-
clophilin, Heterogenous nuclear ribonucleoprotein A2, Hetero-
genous nuclear ribonucleoprotein F, Heterogenous nuclearTable 4
List of proteins identiﬁed using MALDI-TOF from 2D Gels from NCBInr.
Spot ID Identiﬁed protein Accession number M
(D
1. 60 kDa heat shock protein gi|31542947 61
2. Beta actin like protein gi|63055057 42
3. Heterogenous nuclear ribonucleoprotein H gi|5031753 49
4. BiP Protein gi|6470150 71
5. Heterogenous nuclear ribonucleoprotein A2 gi|4504447 36
6. Inorganic pyrophosphatase gi|11056044 33
7. Coﬁlin 1 gi|5031635 18
8. Peroxiredoxin 4 gi|5453549 30
9. Enolase 1 gi|62896593 47
10. Chain A Horf6A Novel Human Peroxidase enzyme gi|331884 25
11. KRT73 Protein gi|80475848 42
12. Alpha globin gi|28549 13
13. Beta globin chain gi|66473265 11
14. Pote Ankyrin domain family member E gi|578804361 77
15. CKB gi|49457530 42
16. EEF1A1 protein gi|48735185 50
17. Eukaryotic translation initiation gi|4503513 45
18. Heterogenous nuclear ribonucleoprotein F gi|4826760 45
19. Endoplasmin precursor gi|4507677 92
20. B23 nucleophosmin gi|82567 31
21. ATP synthase subunit beta gi|32189394 56
22. Transformation upregulated nuclear protein gi|460789 51
23. Alpha tubulin gi|37492 37
24. Chain A Tapasin ERP57 gi|220702 54
25. non-POU domain containing octamer protein
binding isoform 1
gi|34932414 54
26. Chaperonin (Hsp60) gi|306890 61
27. Stress induced phophoprotein 1 gi|5803181 63
28. Rho GDP-dissociation inhibitor 1 gi|4757768 23
29. Triose phosphate isomerase gi|136066 26
30. Cyclophilin gi|181250 22ribonucleoprotein H, Non-POU containing octamer binding protein
and POTE Ankyrin domain family member E. CypB induced by
hypoxia stimulates the survival of HCC via a positive feedback loop
with HIF-1α, demonstrating that CypB is a novel candidate target
for developing chemotherapeutic agents against HCC and colon
cancer [34]. Three differentially expressed proteins (KRT73 pro-
tein, Alpha tubulin and Beta actin like protein) were found to have
role in maintaining cytoskeleton of the cell while three differen-
tially expressed proteins (Enolase, ATP synthase subunit beta and
Triose phosphate isomerase) were seen to play role in ATP
synthesis pathway and maintaining energy reservoir of the cell.olecular mass
a)
Sequence coverage
(%)
Score Fold difference Up or down
,187 18 284 0.65 Down
,318 2 82 1.94 UP
,484 2 117 1.69 Up
,002 7 991 1.52 Up
,041 10 363 2.38 Up
,095 2 64 0.27 Down
,719 5 127 0.42 Down
,749 4 242 2.33 Up
,453 16 843 0.48 Down
,011 9 468 1.53 Up
,270 2 59 0.56 Down
,631 1 71 0.56 Down
,537 2 60 0.46 Down
,074 6 326 0.54 Down
,933 2 137 0.46 Down
,437 3 111 1.79 Up
,035 8 342 1.80 Up
,985 3 67 0.48 Down
,696 6 155 1.80 Up
,080 9 348 1.82 Up
,525 10 681 0.46 Down
,325 1 70 1.82 Up
,492 1 77 0.53 Down
,541 7 337 2.03 Up
,311 5 200 3.7 Up
,157 2 76 0.51 Down
,227 3 142 2.34 Up
,250 6 221 0.62 Down
,894 3 134 0.46 Down
,654 7 281 3.06 Up
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Isoniazid generated reactive oxygen species and induced
apoptosis in Hep3B cells by increasing mRNA and protein level of
various genes playing important roles in apoptosis, oxidative
stress, cell signaling, cell proliferation and differentiation path-
ways. It also decreased the phosphorylation of ERK1 as a result of
which it might not able to activate Nrf2 and its translocation into
the nucleus and could not activate ARE to protect the Hep3B cells
undergoing apoptosis following Isoniazid treatment.5. Materials and method
5.1. Chemicals and biochemicals
All the chemicals were purchased from Sigma Aldrich. DMEM
(Invitrogen), Whole genome expression kit (Ambion), cDNA
synthesis kit (Applied Biosystem), SYBR Green (Roche), Annexin V
FITC kit (Calbiochem), IPG strip, IPG buffer (GE Healthcare), Pri-
mary antibodies Caspase 9, Cyt C, Nrf2, ERK1, Phospho-ERK1, β-
actin, Lamin B (all from Santacruz Biotechnology, USA), Keap1
(Thermo Scientiﬁc, USA) and Secondary antibodies (Santacruz
Biotechnology, USA) were purchased. ERK1 inhibitor was pur-
chased from Calbiochem.
5.2. Cell culture
Hep3B cells were obtained from our institutional cell re-
pository. These cells were maintained at sub-conﬂuence in 95% air
and 5% CO2 in a humidiﬁed atmosphere at 37 °C. DMEM (Dul-
becco's modiﬁed eagles medium) was used for cell cultivation.
Cells were supplemented with 10% FBS, penicillin (100 units/ml)
(both from GIBCO, Invitrogen). Hep3B cells were sub-cultured by
discarding culture media and subsequently washing them with
PBS, then adding Trypsin–EDTA (0.25% Trypsin and 0.53 mM
EDTA) and incubating the cells for 2–5 min at 37 °C in CO2 in-
cubator. Now cells were aspirated by gentle pipetting. Fresh
growth media was added to it and appropriate aliquots of cell
suspension were added to new culture vessel.
5.3. Cell viability assay
In order to calculate 50% growth inhibitory concentration (IC50)
of Isoniazid, Hep3B cells were seeded and grown for 24 h. Now,
cells were treated with different concentrations of Isoniazid. 24 h
later media was removed and cells were incubated in MTT for 4 h.
Then MTT was removed and DMSO was added to each well and
cells were incubated for 45 min in dark. Then OD was taken at
570 nm on Elisa Reader (BIO-TEK).
5.4. Estimation of reactive oxygen species generation (ROS)
Intracellular ROS generated in Hep3B cells following INH
treatment were analyzed using the ﬂuorescent probe 2',7'-di-
chloroﬂuorescin diacetate(DCFDA), a non-ﬂuorescent compound
under normal condition, which is converted into highly ﬂuor-
escent dichloroﬂuorescein (DCF) by ROS. Hep3B cells were seeded
in T25 ﬂask and grown for next 24 h. After 24 h, these cells were
washed with 1 PBS pH 7.4 and treated with different con-
centrations of INH for 24 h. Then, after 24 h cells were scraped in
the media. Now cells were taken in 15 ml centrifuge tube and
centrifuged at 1200 RPM for 5 min at 4 °C. Supernatant was re-
moved and cells were washed with 1 PBS pH 7.4. These cells
were then re-suspended in 500 mL of PBS. Subsequently, 10 mL of
1 mM DCFDA was added to these cells for reactive oxygen species(ROS) estimation. Samples were incubated for 20–30 min at 37 °C
and ﬂuorescence was monitored on a ﬂuorescence activated cell
sorting (FACS) ﬂow cytometer (Beckman Coulter, USA) with ex-
citation wavelength at 488 nm and emission wavelength at
530 nm [13].
5.5. Apoptosis by Annexin V FITC
7105 Hep3B cells were seeded in T25 ﬂasks and grown for
24 h. Then these cells were treated with different concentrations
of Isoniazid for 24 h. FITC Annexin V apoptosis detetion kit I (BD
Bioscience) was used for ﬂow cytometric analysis of apoptotic cells
as per the manufacturer's protocol. Cells were harvested, collected
in 15 ml falcon tube and centrifuged. Now cells were washed with
PBS. Annexin V FITC and PI were added to 1x binding buffer as
manufacturer's protocol. Cells were incubated with annexin V FITC
for 15 min in dark at room temperature. After 15 min, PI was ad-
ded to cell suspension and incubated for 10 min. Subsequently,
apoptosis was analyzed in a Flow Cytometer (FACS Calibur, Becton
Dickinson, USA). Following the same procedure apoptosis induc-
tion was measured in Hep3B cells treated with ERK inhibitor fol-
lowed by 10 and 20 mM of Isoniazid.
5.6. cDNA synthesis and qRT-PCR analysis
Hep3B cells were seeded and treated with 5, 20 and 40 mM of
Isoniazid. Total RNA was isolated with Trizol (Invitrogen) manu-
ally. 5 mg of total RNA was used for cDNA synthesis which was
performed using cDNA synthesis kit (High Capacity cDNA Reverse
Transcription Kit, Applied Biosystems, USA) according to manu-
facturer's protocol. Program for cDNA synthesis was incubation
steps at 25 °C for 10 min, 37 °C for 120 min, 85 °C 5 min and 4 °C
forever. Expression of CytC, Caspase 9, Nrf2, Keap1 and PKCδ genes
was examined using qRT-PCR on LightCycler480 PCR system
(Roche Diagnostics, Germany). The reaction mixture contained
50 ng of analyzed cDNA. The ampliﬁcation of each sample was
performed in triplicate in three independent experiments using a
Light Cycler 480 SYBR Green I master (Roche Diagnostics, Ger-
many) after which Cp values were averaged. For each primer pair,
a melting curve analysis was performed according to instrument.
The program in brief was an initial incubation of 50 °C for 2 min
hold (UDG incubation) and 95 °C for 10 min followed by 40 cycles
at 95 °C for 15 s, 58 °C for 30 s and ﬁnal extension at 72 °C for 20 s.
Differential expression was calculated by 2ΔΔCT method. β-actin
was used as internal control and used to normalize ratios between
samples [14]. Primer sequences for this study are given in Table 1.
5.7. Caspase activity assay
Hep3B cells were seeded and grown for 24 h. After that cells
were treated with 10 and 20 mM of Isoniazid for next 24 h. Then
Caspase 9 and Caspase 3 activity were measured using Caspase
3 and Caspase 9 activity assay kit (Calbiochem, USA) according to
manufacturer's protocol. Caspase activities were measured by
detection with a ﬂuorescence spectrophotometer (Varian, Cary
Eclipse) and the ﬂuorescence was measured at an excitation/
emission wavelength of 400/505 nm.
5.8. Whole gene expression studies
Whole genome expression studies were performed by Microarray
analysis. Total RNA from untreated and INH treated (20 mM) Hep3B
cells was isolated manually by TriZol (Invitrogen). RNA quality and
quantity were checked by formaldehyde gel electrophoresis and
spectrophotometer respectively. RNA samples with approximately
2:1 ratio of 28 S: 18 S rRNA and 260/280 values Z1.8 were used for
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and then second strand was synthesized. Then cRNAwas synthesized
by in vitro transcription and puriﬁed. Further sense strand cDNAwas
synthesized from cRNA and puriﬁed. Now cDNA was fragmented,
labeled and loaded on Human Gene 1.0 ST Array Chip and sealed
with white tough tag. For hybridization, Chip was transferred to the
Hybridization Chamber (Affymetrix Gene Chip Hybridization Oven
645) and incubated for 16 h at 45 °C with 60 rpm speed. After hy-
bridization, Human Gene 1.0 ST Array Chip was washed in wash
chamber (Affymetrix Gene Chip Fluidisc Station 450) to remove the
unbounded fragmented cDNA. After washing, array was scanned
(Affymetrix Gene Chip Scanner) and Microarray Data was analyzed
by Gene Spring software and pathway analysis was performed by
Ingunity Pathway Analysis (IPA) software from Qiagen. Eight differ-
entially regulated genes were validated by quantitative real time PCR.
5.9. Western blot analysis
Cytosolic and nuclear proteins were isolated from Hep3B cells
and liver tissue by ProteoJET cytosolic and nuclear protein ex-
traction kit (Fermentas); according to manufacturer's protocol
proteins were quantiﬁed using Bradford reagent. 50 mg protein
from each sample was separated on 15% SDS-PAGE and transferred
on to a nitrocellulose membrane using a semi-dry electroblotting
apparatus (GE Healthcare, UK). Transfer was examined by Ponceau
S stain and washed with TDW until the stain disappeared. Mem-
brane was blocked overnight in 5% Non-Fat dried milk at 4 °C.
Blocking membrane was washed with 0.1% PBST and probed with
1° antibodies. After 1° antibody incubation, further washing was
done in 0.1% PBST. Membrane was incubated in HRP conjugated 2°
antibody and washed again. Enhanced chemi-luminescent detec-
tion reagent was used to develop the blots. Blots were further used
for densitometric analysis (Image J) and normalization. Experi-
ments were carried out in triplicates and values were averaged.
5.10. 2D gel electrophoresis
Hep3B cells were incubated with INH for 24 h. Now whole cell
lysates were prepared (7 M Urea, 2 M Thiourea ) and total protein
concentration was estimated by Bradford assay. Six gels (three
control and three treatment gels) were run independently in a pH
range of 3–10 (13 cm long IPG strip). IEF was performed with
400 mg of protein samples on immobilized pH gradient IPG strips
(GE Healthcare) in IEF machine. Proteins were separated in the
second dimension by 12% SDS-PAGE, and protein spots were vi-
sualized by coomassie brilliant blue (CBB) staining. All the gels
were scanned with an Image scanner (GE Healthcare) and quan-
titatively analyzed using Image Master 2D Platinum 7.0 software
(GE Healthcare). For each protein spot, from both control and
treatment gels, fold volume change of each spot was calculated by
dividing % volume of treatment spot with control spot. We have
selected the spots whose fold volume change was 41.5 were up-
regulated, whereas o0.65 were down-regulated. Gel to gel and
staining techniques variations were overcome by comparing each
protein spot to a number of other protein spots in the same gel
whose expression did not change under given experimental
conditions.
5.11. Protein identiﬁcation by MALDI-TOF
The differentially appearing protein spots were carefully ex-
cised with a cut pipette tip, collected in eppendorf tubes, and
destained by washing in 50 mM ammonium bicarbonate–ACN
solution followed by two alternative washing steps with 50% ACN
and 50 mM ammonium bicarbonate (ABC). The gel pieces were
dehydrated at room temperature with 100% ACN and covered with10 ml of trypsin (working solution: ng/mL prepared from 100 ng/mL
stock solution in 50 mM ammonium bicarbonate) overnight at
37 °C. The spots were grinded and the peptides were extracted in
10 mL of 70% ACN. The eluate was dried and stored at 80 °C. The
peptides were resuspended in 5 ml of 20% acetonitrile (ACN) and
0.1% triﬂuoro acetic acid (TFA) and sonicated for 3 min before
processing for MS. Thirty measurements were performed using
MALDI-TOF/TOF tandem mass spectrometer (AB4800) and protein
pilot software (Applied Biosystems, Foster City, CA, USA). After
acquisition of spectra, peptide masses for each protein spot were
analyzed by 4000 Series Explorer Software Version 3.5.3 (AB
SCIEX) and a peak list of mono-isotopic masses was generated
prior to MS/MS data search. The tandem mass spectra were stored
in a combined Mascot Generic Format (MGF) ﬁle using “Peak to
Mascot” tool, searched against NCBI-nr database (June 2014)
through Mascot search engine version 2.4.01 (http://www.ma
trixscience.com). Search was performed on the following para-
meters; taxonomy, all; single missed cleavage; precursor mass
tolerance 20 ppm; fragment ion tolerance 0.05 Da; carbamido
methylation of cysteines as ﬁxed and oxidation of methionine as
variable modiﬁcation. Decoy parameter was checked to minimize
the false discovery rate. 70% protein spots were identiﬁed.
5.12. Statistical analysis
GraphPad Prism 5 was used for analyzing mice serum para-
meters and quantitative real time PCR data. Image J was used for
densitometric calculation of Western blotting bands. All the ex-
periments were performed in triplicate independently. ANOVA
method was used for analyzing 2D gel spots. All experiments were
performed in triplicate independently and each image is re-
presentative of one of those images.Conﬂict of interests
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